Matches in Nanopublications for { ?s ?p "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_provenance.
- NP1244663.RAdRWTaTl66cONkbWzV_aIcOV3U6W4x97HS4cYTAesUW8130_assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244663.RAdRWTaTl66cONkbWzV_aIcOV3U6W4x97HS4cYTAesUW8130_provenance.
- NP1244656.RAIfsd6TetLuJlKgodAi7PMzH3fl5e_QI-MfTcVRGS5O8130_assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244656.RAIfsd6TetLuJlKgodAi7PMzH3fl5e_QI-MfTcVRGS5O8130_provenance.
- NP1244662.RA0WavuvvhzcIQiynpsMU-yvq23kut7p2Bkfapp9leuxQ130_assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244662.RA0WavuvvhzcIQiynpsMU-yvq23kut7p2Bkfapp9leuxQ130_provenance.